Zydus unit gets 10 observations from USFDA after inspection
The US Food and Drug Administration (USFDA) inspected the facility at Jarod near Vadodara from April 15 to April 23, the drug maker said in a regulatory filing.
Zydus Lifesciences on Wednesday said the US health regulator has issued ten observations after inspecting its injectable manufacturing plant near Vadodara in Gujarat. The US Food and Drug Administration (USFDA) inspected the facility at Jarod near Vadodara from April 15 to April 23, the drug maker said in a regulatory filing.
The inspection closed with ten observations, it added.
Also Read: PayU gets RBI's in-principle nod to operate as payment aggregator
The company will closely work with the USFDA to address and respond to the observations in an expeditious manner, Zydus Lifesciences said.
Shares of the company were trading 2.79 per cent down at Rs 932.80 apiece on the BSE.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
Retirement Planning: How Rs 8,00,000 one-time investment can create Rs 2,40,00,000 retirement corpus? See calculations to know
Old vs Revised New Tax Regime: How much tax will you save on Rs 7.5 lakh, Rs 10 lakh, Rs 15 lakh, or Rs 20 lakh annual income? See expert analysis
NSC vs FD: Which guaranteed return scheme can give higher maturities on Rs 5,00,000, 7,00,000 & 9,00,000 investments in 5 years
01:41 PM IST